Dr. Bernd Goergen
Partner
About me
| Team | Life Sciences & Chemistry, Partner |
| at HTGF since | 2008 |
| my focus | Life Sciences & Chemie |
| my background | F&E, Marketing, Investment Banking |
CV
Dr Bernd Goergen, Partner, has been a part of High-Tech Gründerfonds’ Life Science Team since early 2008. He holds a PhD in biology and is a certified biotech analyst with the German Association for Financial Analysis and Asset Management (DVFA). He brings with him five years of research experience in the field of virology and immunology and seven years in international diagnostics marketing for German and international companies. Between 2000 and 2007, Dr Goergen also acquired extensive knowledge in M&A and capital market deals while working in the investment banking division of a major German bank.
Four questions for …
Which metaphor do you like to use to describe your job?
HTGF is like the “Sendung mit der Maus”, 24 hours long. Extremely interesting, extremely exhausting. You have to be a believer to keep it up for long.
What is special about your work at a venture capitalist?
The enormous trust that founders place in us every day. And: turning today’s dreams into tomorrow’s reality.
What has changed for the better in the past five years?
There are many more success stories than before. More lighthouses that startups can use as a guide. That inspires and encourages.
What has been your biggest success?
To have accompanied a drug against a serious disease from the preclinical stage to the market as a seed investor. Our 1st unicorn. The MYR. 2021.
My success stories in the HTGF portfolio
neotiv is a spin-off of the Otto von Guericke University in the German city of Magdeburg in close collaboration with the Magdeburg site of the German Centre for Neurodegenerative Diseases …
PEPperPRINT produces customized ultra-high density peptide microarrays and uses individualized peptide libraries for drug development, antibody characterization, and protein biomarker discovery.
Hapila’s counter-current crystallisation process provides a cost effective procedure for purification of active pharmaceutical ingredients, completed by experience in synthesis and particle design.
Guided to exit
Cunesoft provides pioneering online regulatory software for the life sciences and other regulated industries. The SaaS (Software as a Service) based solutions are delivered fully functional to customers and fulfill …
First-in-class Entry-Inhibitor for the treatment of chronic hepatitis Delta
Humedics markets a system for bedside and instantaneous measurement of liver function. Patented device, consumables and a diagnostic drug allow an optimal market offering.
Fiagon develops a new medical navigation system for intraoperative process control and positioning of instruments for ENT, head-/ neck- and neurosurgery.
Social Media & contact
LinkedIn
Dr. Bernd Goergen
Profil